Preclinical Development of a Romidepsin Nanoparticle Demonstrates Superior Tolerability and Efficacy in Models of Human T-Cell Lymphoma and Large Granular Lymphocyte Leukemia
Ipsita Pal(University of Virginia), Owen A. O’Connor(University of Virginia)
Cited by 2
Related Papers
Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs
|Cancer Research|2008|222
The Combination of the Proteasome Inhibitor Bortezomib and the Bcl-2 Antisense Molecule Oblimersen Sensitizes Human B-Cell Lymphomas to Cyclophosphamide
|Clinical Cancer Research|2006|46
BI-69A11 enhances susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting Akt
|British Journal of Cancer|2014|12